J.G.Chemicals Ltd

J.G. Chemicals Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with SEBI's Insider Trading Prohibition Code and will be effective from July 1, 2026, until 48 hours after the declaration of the Unaudited Financial Results for the quarter ending June 30, 2026. All designated persons and their immediate relatives are prohibited from trading during this period. The exact date for the declaration of financial results will be communicated later.

J.G.Chemicals Ltd reports that ₹42.62 million from its IPO proceeds remained unutilized as of March 31, 2026, against the planned deployment for R&D center capital expenditure. The company had utilized ₹131.466 Crores as per the monitoring agency ICRA Limited. The unspent amount is now planned for deployment in Fiscal Year 2027 due to delays in construction and equipment procurement. ICRA's monitoring report confirms no deviation from the original IPO objectives. The objects of the issue remain unchanged.

J.G.Chemicals Ltd's monitoring agency report for the quarter ended March 31, 2026, reveals that ₹42.62 million from the IPO proceeds remains unutilized. These funds were earmarked for capital expenditure related to setting up an R&D Centre. The company plans to deploy the unspent amount in Fiscal Year 2027, subject to shareholder approval. ICRA Limited served as the Monitoring Agency for the IPO, and their report indicates no deviation from the original objectives of the issue.

J.G.Chemicals Ltd approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board recommended a final dividend of 11% (₹1.10 per share). They also approved the re-appointment of cost, internal, and tax auditors. The company plans to utilize the remaining ₹42.62 million from its IPO proceeds for R&D in FY27 due to construction delays.

J.G.Chemicals Ltd's Board of Directors approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board has recommended a final dividend of 11% at ₹1.10 per equity share of ₹10 each, subject to shareholder approval. Additionally, the board approved the re-appointment of M/s Debabrota Banerjee & Associates, SS Kothari Mehta & Co. LLP, and M/s. S Jaykishan as Cost Auditor, Internal Auditor and Tax Auditor respectively for FY 2026-2027. The company plans to utilize the remaining ₹42.62 million from its IPO proceeds towards funding the R&D center in FY27 due to delays in construction and equipment procurement.

J.G.Chemicals Ltd has scheduled a Board of Directors meeting on May 14, 2026, to consider and approve the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026. The board will also consider recommending the payment of a final dividend for the financial year ended March 31, 2026, if any. The trading window closure, which began on April 1, 2026, will remain in effect until 48 hours after the declaration of the results.

J.G.Chemicals Ltd has announced the closure of its trading window for the quarter and year ending 31st March 2026. This closure is in accordance with the Company's 'Insider Trading Prohibition Code' under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed for all Designated Persons of the Company and their Immediate Relatives from 1st April, 2026 till 48 hours after the declaration of the Audited Financial Results for the quarter and financial year ending 31st March, 2026. The exact date of consideration of the Audited Financial Results will be intimated in due course. All Designated Persons, their immediate relatives, and other Insiders under the PIT Regulations are directed not to trade in the securities of the Company during this closure period.

J.G.Chemicals Ltd. announced the outcome of its Board Meeting held on 14th February 2026. The Board approved the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended 31st December 2025. The company's revenue from operations stands at INR 595.99 million for the quarter and INR 2,010.28 million for the nine months. The total income for the quarter is INR 2,132.58 million and INR 2,868.41 million for the nine months. The company operates mainly in the manufacturing and selling of Zinc based products. The Earnings Per Equity Share (of INR 10 each) for the quarter is not annualised.

J.G.Chemicals Ltd, an ISO 9001, 14001, 45001 certified company, has reported its unaudited financial standalone and consolidated results for the quarter ended 31.12.2025. The company's revenue from operations has increased by 15.6% YoY to ₹ 595.99 million. The total income for the quarter stands at ₹ 2,132.58 million, with a profit after tax of ₹ 148.21 million. The company operates mainly in the manufacturing and selling of Zinc based products.

J.G. Chemicals Ltd has submitted the final Monitoring Agency report for the quarter and nine months ended December 31, 2025. The report, prepared by ICRA Limited, indicates no deviation in the utilization of proceeds from the Initial Public Offer (IPO). The company has utilized the funds in line with the objects of the issue. The monitoring agency report does not constitute a commentary on the quality of the objects of the issue or assurance on the outcome of spending. The report also highlights that civil/construction work related to the R&D unit has started and machinery towards setting up the R & D Centre has been procured.